Happiest Minds shares dropped 11% after founder Ashok Soota announced a 22.1% stake sale to ITC Infotech for Rs 1,330 crore. The proceeds will fund his healthcare research and hospital expansion ventures. The move coincides with a broader merger plan between Happiest Minds and ITC Infotech, aiming for $1 billion in revenue by FY28.
Happiest Minds Technologies witnessed an 11% decline in its share price on September 1, 2026, following the announcement that founder Ashok Soota is divesting a 22.1% stake in the company. The stake sale, valued at approximately Rs 1,330 crore, is being executed in two tranches at prices of Rs 390 and Rs 400 per share.
The divestment is part of a larger structural shift involving the merger of Happiest Minds with ITC Infotech. Under the terms of this deal, shareholders will receive 25 shares of ITC Infotech for every 81 shares held in Happiest Minds. This merger is intended to create an AI-first global technology enterprise with a stated goal of reaching $1 billion in revenue by fiscal year 2028. Following this transition, Ashok Soota will retain a 7.55% stake in the combined entity.
Ashok Soota has confirmed that the proceeds from this stake sale are primarily earmarked for his healthcare ventures, specifically Skan Research Trust and Happiest Health. Skan Research Trust, which focuses on neurological research and the study of ageing, is currently planning to expand its footprint with a new 2-lakh square-foot research facility. Simultaneously, Happiest Health is moving toward scaling its operations by establishing a network of specialized diagnostic centers and hospitals. This shift highlights a significant pivot in Soota’s personal capital allocation, moving away from his core technology focus toward the medical sciences sector.
The negative reaction in the stock market suggests that investors are currently processing the implications of the merger terms and the founder’s reduced stake. Market sentiment often shifts during major corporate amalgamations, particularly when there is uncertainty regarding share swap ratios and changes in leadership involvement. Furthermore, while the company has outlined an ambitious revenue target, the technology sector is currently navigating a competitive landscape that demands continuous innovation and operational scale.
For investors, several factors remain key to monitoring the future of this transition. Firstly, the successful execution of the merger between Happiest Minds and ITC Infotech requires regulatory approvals and a smooth integration of the two distinct organizational structures. Secondly, the expansion of the healthcare ventures—Skan Research Trust and Happiest Health—carries inherent execution risks, as building large-scale specialized hospital and research infrastructure involves significant capital spending and long-term operational planning.
Investors will likely watch for updates on the integration progress between the two IT firms, the timeline for the healthcare facility commissioning, and any further communication from management regarding the transition. The long-term impact on shareholder value will depend on whether the combined technology entity can meet its ambitious growth targets while managing the complexities of such a large-scale corporate consolidation.